These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6991356)

  • 1. Renin-angiotensin-aldosterone in cirrhotic ascites.
    Martin A; Sturniolo GC; Naccarato R
    Gastroenterology; 1980 May; 78(5 Pt 1):1122-3. PubMed ID: 6991356
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion.
    Wong PY; Carroll RE; Lipinski TL; Capone RR
    Gastroenterology; 1979 Dec; 77(6):1171-6. PubMed ID: 499705
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cirrhotic ascites and the renin-angiotensin system].
    Gonvers JJ; Loup P; Hofstetter JR; Brunner HR
    Schweiz Med Wochenschr; 1980 May; 110(22):869-71. PubMed ID: 6996085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 5. [The renin-angiotensin system in patients with cirrhosis of the liver].
    Serebrovskaia IuA; Loginov AS; Uchitel' IA; Isakova ZS
    Ter Arkh; 1971 Dec; 43(12):44-9. PubMed ID: 4334611
    [No Abstract]   [Full Text] [Related]  

  • 6. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z; Feng H; Leng X; Ma F; Wang B; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites.
    Saito I; Saruta T; Eguchi T; Nakamura R; Kondo K; Iyori S; Kato E
    Jpn Heart J; 1978 Sep; 19(5):741-7. PubMed ID: 731936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of renin activity in blood plasma].
    Serebrovskaia IuA; Uchitel' IA
    Lab Delo; 1970; 7():421-6. PubMed ID: 4098137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
    Gu XB; Chen HK; Zhu YF; Pei H; Liu XY
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):370. PubMed ID: 15225438
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites.
    Hata T; Ogihara T; Mikami H; Nakamaru M; Mandai T; Kumahara Y
    Jpn Circ J; 1979 Jan; 43(1):37-41. PubMed ID: 449013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of plasma renin activity in edematous cirrhosis. Influence of various depletive treatments].
    Cottin S; Miniconi P; Belet JL; Cadudal JL; Talmant JC; Bailleux A
    Sem Hop; 1973 Apr; 49(19):1357-63. PubMed ID: 4355382
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinoma.
    Kondo M; Nagano H; Sakon M; Hayashi S; Okami J; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
    Hepatogastroenterology; 2003; 50(50):504-6. PubMed ID: 12749257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease.
    Sellars L; Shore AC; Wilkinson R; James OF; Robson V
    Eur J Clin Invest; 1981 Aug; 11(4):299-304. PubMed ID: 6795046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ANP in the cirrhotic patient. A clinical contribution].
    Parlapiano C; Labellarte A; Primi F; Cervellini P; La Torre F; Paparo SB; Baccarini S; Di Nardo A
    Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estimation of plasma renin, angiotensin II and urinary aldosterone in patients with cirrhosis of liver and its clinical significance].
    Tang ZD
    Zhonghua Nei Ke Za Zhi; 1982 Oct; 21(10):602-4. PubMed ID: 6759071
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The renin-angiotensin-aldosterone system in chronic diseases of the liver].
    Loginov AS; Khodarev NN; Astaf'eva OV
    Sov Med; 1988; (4):9-11. PubMed ID: 3043716
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood catecholamines in liver cirrhosis].
    Greco AV; Ghirlanda G; Bochicchio GB; Caputo S; Uccioli L; Rebuzzi AG
    Minerva Med; 1985 Oct; 76(41):1911-5. PubMed ID: 2865701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.
    Bosch J; Arroyo V; Betriu A; Mas A; Carrilho F; Rivera F; Navarro-Lopez F; Rodes J
    Gastroenterology; 1980 Jan; 78(1):92-9. PubMed ID: 7350041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.